Categories
All News

Precision Medicine Market to Witness Massive Growth During 2021-2027 | Johnson & Johnson, IBM, GE Healthcare, Illumina, Roche, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Novartis, Abbott Laboratories, Illumina, Roche, Biomrieux Sa, Cepheid, Qiagen, Randox Laboratories, Healthcore

 Precision Medicine  Market Research Report

LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Precision Medicine Market Size, Status and Forecast 2021-2027“. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Precision Medicine market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Precision Medicine market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Precision Medicine market.

Top Companies/Manufacturers:
Johnson & Johnson, IBM, GE Healthcare, Illumina, Roche, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Novartis, Abbott Laboratories, Illumina, Roche, Biomrieux Sa, Cepheid, Qiagen, Randox Laboratories, Healthcore
Market Segment by Product Type:
Diagnostics
Therapies Precision Medicine
Market Segment by Application:
Oncology
Neurosciences
Immunology
Respiratory
Others


Get PDF Sample Copy of the Report @

https://www.qyresearch.com/sample-form/form/2620779/global-precision-medicine-market

For Customization in the Report Drop Your Query Here:

https://www.qyresearch.com/customize-request/form/2620779/global-precision-medicine-market

Buy Now:

https://www.qyresearch.com/settlement/pre/47ed5c8b516d971a352d084cb948ae7d,0,1,global-precision-medicine-market


Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Precision Medicine market.

Key questions answered in the report:

  • What is the growth potential of the Precision Medicine market?
  • Which product segment will grab a lion’s share?
  • Which regional market will emerge as a frontrunner in the coming years?
  • Which application segment will grow at a robust rate?
  • What are the growth opportunities that may emerge in the Precision Medicine industry in the years to come?
  • What are the key challenges that the global Precision Medicine market may face in the future?
  • Which are the leading companies in the global Precision Medicine market?
  • Which are the key trends positively impacting the market growth?
  • Which are the growth strategies considered by the players to sustain hold in the global Precision Medicine market

TOC

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2016-2027)
2.2 Precision Medicine Growth Trends by Regions
2.2.1 Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Precision Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Precision Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Precision Medicine Industry Dynamic
2.3.1 Precision Medicine Market Trends
2.3.2 Precision Medicine Market Drivers
2.3.3 Precision Medicine Market Challenges
2.3.4 Precision Medicine Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Precision Medicine Players by Revenue
3.1.1 Global Top Precision Medicine Players by Revenue (2016-2021)
3.1.2 Global Precision Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Precision Medicine Revenue
3.4 Global Precision Medicine Market Concentration Ratio
3.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2020
3.5 Precision Medicine Key Players Head office and Area Served
3.6 Key Players Precision Medicine Product Solution and Service
3.7 Date of Enter into Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Precision Medicine Breakdown Data by Type
4.1 Global Precision Medicine Historic Market Size by Type (2016-2021)
4.2 Global Precision Medicine Forecasted Market Size by Type (2022-2027) 5 Precision Medicine Breakdown Data by Application
5.1 Global Precision Medicine Historic Market Size by Application (2016-2021)
5.2 Global Precision Medicine Forecasted Market Size by Application (2022-2027) 6 North America
6.1 North America Precision Medicine Market Size (2016-2027)
6.2 North America Precision Medicine Market Size by Type
6.2.1 North America Precision Medicine Market Size by Type (2016-2021)
6.2.2 North America Precision Medicine Market Size by Type (2022-2027)
6.2.3 North America Precision Medicine Market Size by Type (2016-2027)
6.3 North America Precision Medicine Market Size by Application
6.3.1 North America Precision Medicine Market Size by Application (2016-2021)
6.3.2 North America Precision Medicine Market Size by Application (2022-2027)
6.3.3 North America Precision Medicine Market Size by Application (2016-2027)
6.4 North America Precision Medicine Market Size by Country
6.4.1 North America Precision Medicine Market Size by Country (2016-2021)
6.4.2 North America Precision Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada 7 Europe
7.1 Europe Precision Medicine Market Size (2016-2027)
7.2 Europe Precision Medicine Market Size by Type
7.2.1 Europe Precision Medicine Market Size by Type (2016-2021)
7.2.2 Europe Precision Medicine Market Size by Type (2022-2027)
7.2.3 Europe Precision Medicine Market Size by Type (2016-2027)
7.3 Europe Precision Medicine Market Size by Application
7.3.1 Europe Precision Medicine Market Size by Application (2016-2021)
7.3.2 Europe Precision Medicine Market Size by Application (2022-2027)
7.3.3 Europe Precision Medicine Market Size by Application (2016-2027)
7.4 Europe Precision Medicine Market Size by Country
7.4.1 Europe Precision Medicine Market Size by Country (2016-2021)
7.4.2 Europe Precision Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic 8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Market Size (2016-2027)
8.2 Asia-Pacific Precision Medicine Market Size by Type
8.2.1 Asia-Pacific Precision Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Precision Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Precision Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Precision Medicine Market Size by Application
8.3.1 Asia-Pacific Precision Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Precision Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Precision Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Precision Medicine Market Size by Region
8.4.1 Asia-Pacific Precision Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Precision Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Precision Medicine Market Size (2016-2027)
9.2 Latin America Precision Medicine Market Size by Type
9.2.1 Latin America Precision Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Precision Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Precision Medicine Market Size by Type (2016-2027)
9.3 Latin America Precision Medicine Market Size by Application
9.3.1 Latin America Precision Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Precision Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Precision Medicine Market Size by Application (2016-2027)
9.4 Latin America Precision Medicine Market Size by Country
9.4.1 Latin America Precision Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Precision Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Market Size (2016-2027)
10.2 Middle East & Africa Precision Medicine Market Size by Type
10.2.1 Middle East & Africa Precision Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Precision Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Precision Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Precision Medicine Market Size by Application
10.3.1 Middle East & Africa Precision Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Precision Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Precision Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Precision Medicine Market Size by Country
10.4.1 Middle East & Africa Precision Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Precision Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Precision Medicine Introduction
11.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 IBM
11.2.1 IBM Company Details
11.2.2 IBM Business Overview
11.2.3 IBM Precision Medicine Introduction
11.2.4 IBM Revenue in Precision Medicine Business (2016-2021)
11.2.5 IBM Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Precision Medicine Introduction
11.3.4 GE Healthcare Revenue in Precision Medicine Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Precision Medicine Introduction
11.4.4 Illumina Revenue in Precision Medicine Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Precision Medicine Introduction
11.5.4 Roche Revenue in Precision Medicine Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Details
11.6.2 Laboratory Corporation of America Holdings Business Overview
11.6.3 Laboratory Corporation of America Holdings Precision Medicine Introduction
11.6.4 Laboratory Corporation of America Holdings Revenue in Precision Medicine Business (2016-2021)
11.6.5 Laboratory Corporation of America Holdings Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Precision Medicine Introduction
11.7.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2016-2021)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Precision Medicine Introduction
11.8.4 Novartis Revenue in Precision Medicine Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Precision Medicine Introduction
11.9.4 Abbott Laboratories Revenue in Precision Medicine Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Precision Medicine Introduction
11.10.4 Almac Group Revenue in Precision Medicine Business (2016-2021)
11.10.5 Almac Group Recent Development
11.11 Intel Corporation
11.11.1 Intel Corporation Company Details
11.11.2 Intel Corporation Business Overview
11.11.3 Intel Corporation Precision Medicine Introduction
11.11.4 Intel Corporation Revenue in Precision Medicine Business (2016-2021)
11.11.5 Intel Corporation Recent Development
11.12 Biomrieux Sa
11.12.1 Biomrieux Sa Company Details
11.12.2 Biomrieux Sa Business Overview
11.12.3 Biomrieux Sa Precision Medicine Introduction
11.12.4 Biomrieux Sa Revenue in Precision Medicine Business (2016-2021)
11.12.5 Biomrieux Sa Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Precision Medicine Introduction
11.13.4 Cepheid Revenue in Precision Medicine Business (2016-2021)
11.13.5 Cepheid Recent Development
11.14 Qiagen
11.14.1 Qiagen Company Details
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Precision Medicine Introduction
11.14.4 Qiagen Revenue in Precision Medicine Business (2016-2021)
11.14.5 Qiagen Recent Development
11.15 Randox Laboratories
11.15.1 Randox Laboratories Company Details
11.15.2 Randox Laboratories Business Overview
11.15.3 Randox Laboratories Precision Medicine Introduction
11.15.4 Randox Laboratories Revenue in Precision Medicine Business (2016-2021)
11.15.5 Randox Laboratories Recent Development
11.16 Healthcore
11.16.1 Healthcore Company Details
11.16.2 Healthcore Business Overview
11.16.3 Healthcore Precision Medicine Introduction
11.16.4 Healthcore Revenue in Precision Medicine Business (2016-2021)
11.16.5 Healthcore Recent Development 12 Analyst’s Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.